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Background: Female sex workers who inject drugs (FSW-IDUs) are at risk of acquiring HIV, sexually transmitted
infections (STI) and blood-borne infections through unprotected sex and sharing injection equipment. We
conducted a 2×2 factorial randomized controlled trial to evaluate combination interventions to simultaneously
reduce sexual and injection risks among FSW-IDUs in Tijuana and Ciudad Juarez, Mexico.
Methods/design: FSW-IDUs ≥18 years reporting sharing injection equipment and unprotected sex with clients
within the last month were randomized to one of four conditions based on an a priori randomization schedule,
blinding interviewer/counselors to assignment. Due to the extreme vulnerability of this population, we did not
include a control group that would deny some women access to preventive information. All women received
similar information regardless of group allocation; the difference was in the way the information was delivered and
the extent to which women had an interactive role. Each condition was a single 60-minute session, including either
an interactive or didactic version of an injection risk intervention and sexual risk intervention. Women underwent
interviewer-administered surveys and testing for HIV, syphilis, gonorrhea, Chlamydia, and Trichomonas at baseline
and quarterly for 12 months. Combined HIV/STI incidence will be the primary outcome. Secondary outcomes are
proportionate reductions in sharing of injection equipment and unprotected sex with clients.
Discussion: Of 1,132 women, 548 (48.4%) were excluded (88.9% were ineligible; 11.1% refused to participate or did
not return); 584 eligible women enrolled (284 in Tijuana; 300 in Ciudad Juarez). All 584 participants completed the
baseline interview, provided biological samples and were randomized to one of the four groups. During follow-up,
17 participants (2.9%) were lost to follow-up, of whom 10 (58.8%) had died, leaving 567 participants for analysis.
This study appears to be the first intervention to attempt to simultaneously reduce injection and sexual risk
behaviors among FSW-IDUs. The factorial design will permit analysis to determine whether the combination of the
two interactive interventions and/or its respective components are effective in reducing injection and/or sexual
risks, which will have direct, tangible policy implications for Mexico and potentially other resource-poor countries.
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Relationships between drug and alcohol use and unpro-
tected sex have been well documented among female
sex workers (FSWs) since early in the HIV epidemic
[1-3]. In Holland [4], FSWs who reported engaging in
sex work while ‘high’ were more likely to report unsafe
sex. In the UK [5], FSWs’ drug use was associated with
having unprotected sex in exchange for more money.
Unfavorable working conditions including low earnings,
limited access to condoms and violence from clients or
intimate partners can lead some FSWs to acquiesce to
demands for unsafe sex [6,7], especially if they are suffer-
ing from withdrawal symptoms or rely on a partner for
drugs [8]. Some FSWs exchange sex primarily for drugs
[2,9], and/or use drugs with clients, which may increase
their risk of sharing injection equipment.
Since female sex workers who inject drugs (FSW-
IDUs) are at high risk of becoming infected with HIV
through unprotected sexual intercourse and sharing in-
jection equipment with intimate partners, clients and
peers, this subgroup meets criteria for a ‘bridge’ popula-
tion that is associated with generalized HIV epidemics
[10]. Overlap between FSW and IDU populations is es-
pecially high in parts of Southeast and Central Asia [11],
Russia [12,13], and Argentina [14] and is a growing con-
cern in some Latin American countries, such as Mexico
[15].
Overlap between FSW and IDU populations in Mexico-
U.S. border cities is due at least in part to a number of en-
vironmental influences. Sex work is quasi-legal in Mexico,
and some Mexican cities (e.g., Tijuana, Baja California),
maintain zona rojas (red zones) where sex work is toler-
ated among women aged 18 and older, provided that they
subject to quarterly HIV/STI testing and are issued a work
permit. Other cities such as Ciudad (Cd.) Juarez, Chihua-
hua tolerate sex work but do not regulate it. Cd. Juarez
began gentrifying their zona roja district in 2008, leading
FSWs to become dispersed. Both cities have experienced
high levels of community-based violence associated with
warring drug cartels, but this situation has been particu-
larly severe in Cd. Juarez.
The proximity of Tijuana and Ciudad Juarez to the
U.S. cities of San Diego, CA and El Paso, TX draws cli-
ents and sex tourists from the U.S. and internationally.
In an earlier study, two thirds of FSWs in these cities
reported having clients from the U.S., and those that did
were more likely to engage in more HIV risk behaviors.
Although no robust estimates of the number of FSWs
exist for either city, there were an estimated 9,000 FSWs
in Tijuana [16] and 4000 FSWs in Ciudad Juarez in 2005
[17].
Mexico is one of the most important sources of heroin
and methamphetamine entering the U.S. [18] and it is
estimated that 70% of all cocaine entering the U.S.passes through Mexico en route from South America.
As a consequence, illicit drug use has increased in
Tijuana and Cd. Juarez over the past decade as local
consumption markets emerged along drug trafficking
routes [18]. In Mexico overall, men were 13 times more
likely than women to have ever used an illicit drug, but
in Tijuana the ratio was 6:1, indicating a high proportion
of female drug users. Although no official estimates of
the number of IDUs exist in Mexico, there were an esti-
mated 10,000 IDUs in Tijuana in 2005 [19] and about
6,500 ‘heavy heroin users’ in Cd. Juarez [20] in 2001.
Overlapping sex work and drug use along Mexico’s
northern border has influenced local HIV epidemics. By
the end of 2005, the estimated number of HIV-infected
persons in Mexico was 182,000 [21] with HIV preva-
lence ~0.6% among adults aged 15–49. However, HIV
prevalence was nearly double in Baja California, which
ranked 2nd in HIV prevalence among Mexico’s 32 states
[21].Although Chihuahua ranked 14th in AIDS incidence
across Mexico, a high proportion of cases were attribu-
ted to injection drug use [21]. These national and state-
level HIV/AIDS surveillance statistics mask a burgeon-
ing HIV epidemic in Tijuana and Cd. Juarez, where HIV
prevalence among FSWs rose from 2% in 2003 to 8%,
and 12% among FSW-IDUs by 2006 [8]. Almost half of
FSW-IDUs in these two cities had at least one sexually
transmitted infection (STI), such as HIV, active syphilis,
gonorrhea or Chlamydia [8]. In Tijuana, HIV prevalence
among female IDUs was 10% in 2006 [22]. Many FSWs
in Tijuana and Cd. Juarez report using stimulants like
methamphetamine or cocaine to help them cope or stay
awake [23], which is of concern since injection and non-
injection use of these stimulants was independently
associated with HIV infection among FSWs in both [23]
cities.
In response to rising HIV prevalence among FSWs in
Tijuana and Cd. Juarez, members of our research team
conducted a two-arm randomized trial to determine
whether a theoretically-based intervention using motiv-
ational interviewing was successful in increasing condom
use among FSWs in these cities. Conducted from 2004–
2006, the study found a 40% reduction in combined
HIV/STI incidence associated with this intervention,
which was called Mujer Segura (Safe Women) [17]. The
intervention group also reported higher proportions of
protected sex acts compared to the control arm. How-
ever, compared to FSWs who had never injected drugs,
FSW-IDUs improved less and rates of needle sharing did
not change. This was not surprising since the Mujer
Segura intervention did not focus on reducing drug-
related risks, nor did it provide skills to negotiate con-
dom use within the context of drug use.
The high overlap between FSW and IDU populations
in countries that bear a high or growing burden of HIV
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safer sex or safer injection will be of limited effective-
ness. Yet we could identify no interventions that simul-
taneously address both sexual and injection drug-related
risks for FSW-IDUs. Similarly, we could find no pub-
lished intervention that taught safer sex negotiation
skills within the context of ongoing drug use by FSWs,
their regular partners or clients.
The protocol herein describes a four-arm factorial
randomized control trial called Mujer Mas Segura
(Safer Women) to simultaneously test the efficacy of
two behavioral interventions-- offered in interactive
and didactic formats – aimed at a) increasing condom
use in the context of ongoing drug use; and b) decreas-
ing syringe and paraphernalia sharing among FSW-
IDUs in Tijuana and Cd. Juarez. We hypothesized that
the joint effect of the interactive format of these inter-
ventions will generate greater risk reductions compared
to the didactic formats of these interventions. Further-
more, we aimed to examine the extent to which
theoretically-based components of these interventions
(i.e., knowledge, self-efficacy, outcome expectancies,
attitudes, and intentions) represent underlying mechan-
isms of change in primary outcomes (i.e., sexual and
injection-related risk reductions).
Mujer Mas Segura: study design and methods
The study protocol was submitted, reviewed and
approved by Institutional Review Boards in the US (Uni-
versity of California, San Diego, [UCSD]), and Mexico
(Centro Nacional para la Prevencion de VIH/SIDA
[CENSIDA], Universidad Autonoma de Ciudad Juarez
[UACJ] and Hospital General de Tijuana [HGTJ]. In
addition, a Data Safety Monitoring Board (DSMB) was
formed with experts in the field of public health re-
search, and knowledgeable of the target population of
sex workers and injection drug users. To this end,
DSMB members reviewed on a regular basis the study’s
data on recruitment, retention, adverse events and pre-
liminary estimates of study endpoints (i.e., incidence of
HIV and sexually transmitted infections) identifying no
issues during the study implementation.
Study sample
Study recruitment took place between October 28, 2008
through May 31, 2010 in Tijuana and November 15,
2008 through July 30, 2010 in Ciudad Juarez.
Inclusion criteria
Participants were required to be: (i) biologically female,
(ii) at least 18 years old, (iii) report having exchanged
sex for money, drugs, shelter or goods in the last month,
(iv) report having injected drugs at least once in the last
month, (v) test HIV-negative at baseline, (vi) agree toreceive antibiotic treatment for Chlamydia, gonorrhea or
syphilis if they tested positive at baseline, (vii) report
having had unprotected vaginal or anal sex with male
clients at least once during the previous month and (viii)
report having shared needles, syringes or other injection
paraphernalia (i.e., cookers, cotton, rinse water) at least
once within the last month.
Exclusion criteria included
(i) consistent use of condoms for vaginal and anal sex with
all clients during the previous month; (ii) being <18 years
old; (iii) being trans-gendered or biologically male; (iv)
testing HIV-positive; (v) having been enrolled in Mujer
Segura, the pilot study of Mujer Mas Segura or another
intervention study; (vi) consistently practicing safer sex
with clients within the last month, and vii) not having
injected with a used syringe or injection equipment (i.e.,
cotton filter, cookers, rinse water) that had been used by
another person in the last month. The age exclusion cri-
terion was imposed because it is illegal for women
<18 years old to engage in prostitution in Mexico. Under-
age sex workers were referred to partner NGOs for ser-
vices. Exclusion of transgendered sex workers was
imposed because they have different relationship dynam-
ics and sociocultural risk profiles that warranted a poten-
tially different intervention. Pregnancy was not an
exclusion criterion; we performed rapid pregnancy tests
for women who were unsure if they were pregnant to
optimize their STI treatment and referred these women to
prenatal care following their visit.
Description of the Field Teams, At both sites, the field
teams were comprised of outreach workers (2), inter-
viewers (2–3), and field nurses (1–2).
Outreach workers/promotores: Promotore/as were former or
active IDUs, FSWs or FSW-IDUs who were knowledgeable
of the target population and were well recognized in the
community. On average, there were usually 2 promotore/
as to assist with recruitment and follow-up activities in Ti-
juana and Ciudad Juarez. Most were female but for safety
reasons, one male promotore at each site assisted female
staff during field activities. Male promotores would not ap-
proach the potential participants directly but would unob-
trusively support the female promotoras to make sure there
were no safety concerns.
Interviewers/Counselors: were female college-level gradu-
ates such as social workers, psychologists, and health profes-
sionals who had>3 years’ experience working in the
community with high risk populations at each site. All of the
interviewers were trained on HIV/STI pre- and post-test
counseling following national guidelines from the US (US
Centers for Disease Control and Prevention) and Mexico
(CENSIDA), which were consistent with one another.
Field nurse: There were at least 2 nurses available at each
site that were responsible for vaginal swab and venipuncture
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field nurses had vast experience and skills necessary to col-
lect biological samples. Field nurses were female and quali-
fied to do HIV/STI pre- and post-test counseling. Field
nurses were also responsible for preparing the biological
samples for shipping to San Diego.
Participant recruitment
We considered sampling strategies to recruit hidden
populations, such as respondent driven sampling (RDS)
[24,25] and time location sampling (TLS) [24,25]. We
elected not to use RDS since a previous study in Tijuana
using RDS recruited a low number of female IDUs [26],
who tended to have small network chains. TLS was ini-
tially attractive, but was eventually ruled out since fre-
quent police crackdowns, army presence and street
violence prevented us from maintaining a schedule
where we could select venues at random dates and
times. Thus, targeted sampling techniques were used,
whereby local NGOs already working with FSWs and
IDUs were approached to collaborate in the study. Pro-
ject staff joined local NGO staff during their outreach
activities at venues frequented by FSWs and IDUs,
which included motels, hotels, brothels, shooting galler-
ies, bars, alleys and street corners in both cities. Poten-
tial participants were approached about the study and
those who expressed an interest in participating in the
study were referred to the project offices or a mobile
unit for eligibility screening.
Participant screening
A five-minute survey screener was developed to deter-
mine if participants met project eligibility criteria. It
included questions such as age, whether participants had
ever engaged in exchange of sex for money, drugs, goods
or shelter or injected drugs and the date they last did so,
date of last unprotected vaginal or anal sex act with a
client, date they last shared syringes and/or injection
paraphernalia (i.e., cotton, cooker, rinse-water), city of
residence and intention to move in the next year. A few
‘red herring’ questions (e.g., child care needs, homeless-
ness, border crossing) were also included to prevent
women from guessing the eligibility criteria. Staff also
checked for track marks to ensure that the participant
had injected drugs recently. Women deemed potentially
eligible underwent the informed consent process as well
as HIV rapid testing. Women who were too inebriated/




The baseline interview took approximately 40 minutes
to complete and was theory-driven and translated intoSpanish and back-translated into English by our bilin-
gual, bicultural staff, who also reviewed questions for
cultural and linguistic appropriateness. All behavioral
measures were administered using computer-assisted
personal interviewing (CAPI; NOVA software, MD,
USA).
The interview measured socio-demographic and family
background (city or town of birth, education, first lan-
guage, family ties, # of children and dependents, marital
status, religiosity or spirituality, sexual abuse, living situ-
ation). Financial need was assessed by five items that
asked about the participant’s earning from sex work,
other sources, number of people who were financial
dependents, and the nature of relationship with financial
dependents. History, practices and environmental influ-
ences regarding substance use included age at first use
of alcohol and specific drugs, amount and frequency of
alcohol consumed, types of substances used alone and in
combination and routes of administration, syringe re-
use, receptive and distributive sharing of syringes, injec-
tion and non-injection paraphernalia, frequency of injec-
tion and syringe sharing, syringe cleaning, needing help
injecting, drug use and needle sharing in jail and history
of drug treatment. We also collected data on sources of
syringes, ease of obtaining sterile syringes, barriers to
syringe purchase at pharmacies, shooting gallery attend-
ance, and frequency of arrest and incarceration for
charges related to drug possession and paraphernalia.
FSWs were also asked to report their use of alcohol and
specific drugs preceding and during sex with regular,
casual and client partners for the past month.
Sexual behaviors included number and frequency of un-
protected vaginal and anal sex with clients, spouse or steady
partner and casual male partners in the past month; num-
ber of partners who inject drugs, number of female sex
partners, and use of the male and/or female condom.
Contextual factors included working conditions: work
setting (e.g., brothel, street, bar, motel, hotel), the type of
sex worker (e.g., dance hostess, bar maid, street worker),
nature of relationship with pimp or manager (if applicable,
including degree of financial independence, control over
client selection), degree of protection from drunk or ag-
gressive clients, client characteristics, demands for unpro-
tected sex, aggression or violence, amount received for
protected vs. unprotected vaginal and anal sex. We also
asked about perceived changes in HIV/STI prevention ser-
vices such as availability of condoms, sterile syringes, HIV
testing and medical care, and perceived changes in the en-
vironment such as presence of police, army, community
violence, and torn down buildings.
Social Influence measures assessed the extent to which
social network members engaged in high risk behaviors.
Women were asked to think of other FSWs with whom
they have the most contact or feel closest to; for each of
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extent to which this person engages in the following
behaviors: sex without condoms; sex with multiple part-
ners without condoms; drug use before or during sex; al-
cohol use before or during sex; and unsafe injection
drug use. Ratings were made on a 4-point scale ranging
from 1 (not at all) to 4 (very often). Intrapersonal factors
included depressed mood which was assessed using the
20-item Center for Epidemiologic Studies Depression
Scale (CES-D) [27]. Self-esteem was assessed using the
Rosenberg scale, an 8-item global construct assessing
the regard in which one holds oneself [28]. These intra-
personal measures had been used previously in Mujer
Segura.
Mechanisms of change variables
HIV and HCV knowledge
We utilized a measure of knowledge consisting of 18
items [29], which assessed awareness of the importance
of condom use with respect to HIV/STI prevention (e.g.,
“People who have been infected with HIV quickly show
serious signs of illness”). Response categories were True/
False.
Self-efficacy towards safer injection
This scale was developed in the DUIT intervention study
[30] to assess the extent to which IDUs feel they can
practice safer injection techniques (e.g., “I can avoid
sharing needles even if have had sex without condoms
with this person”; “I can avoid sharing needle even if I
am in withdrawal [mallila]”). Responses were coded on
a 4-point scale (1 = Strongly Disagree to 4 = Strongly
Agree).
Self-efficacy towards condom use
This 5-item measure was based on a scale developed by
Jamner and colleagues [31] and was used in Mujer
Segura. Participants were asked to indicate the extent to
which they are able to use a condom properly with cli-
ents, using the same 4-item response categories as
above.
Peer norms about safer injection
This was a 4-item scale which was previously developed
for the DUIT intervention study (alpha = 0.89) [30]. Par-
ticipants were asked to indicate the extent to which they
felt sharing of syringes and injection equipment was nor-
mative (e.g., “People I inject with think that sharing coo-
kers, cotton or water should never be shared when they
inject”).
Outcome expectancies
Participants responded to a 6 item outcome expectancy
scale that was developed in Mujer Segura which used a4-point scale ranging from 1 (Strongly Disagree) to 4
(Strongly Agree) [32]. Sample items were “I believe that
using condoms will protect me from getting HIV”.
Supplemental survey
To minimize respondent burden, a supplemental ques-
tionnaire was administered one month after the baseline
survey. The following domains were included in the sup-
plemental survey: mobility patterns, including circular
migration and migration to U.S. or other locations. We
also included Straus’ 39-item measure of intimate part-
ner violence [33] (e.g., ‘Has your partner choked or
strangled you’?), that had been piloted in our settings
(alpha = 0.87). We also added questions to determine the
extent to which women had experienced violence due to
conflict over drugs or money with partners, pimps and
clients. We assessed power relationship between women
and their husband or steady partner using a 4-item scale
derived from the Sexual Relationship Power Scale [34]
(e.g., “when you and your partner argue, your partner
gets his way most of the time”).
Randomization
After the screening was completed, participants were
assigned to one of four groups based on a randomization
schedule that was generated a priori by the study statis-
tician. The randomization schedule was not disclosed to
the interviewers, ensuring that interviewers were blind
to group assignment.
Overview of intervention and control conditions
584 HIV-negative women meeting our eligibility criteria
(284 in Tijuana and 300 in Ciudad Juarez) were rando-
mized to one of four conditions in a 2×2 factorial design
as described below (see Figure 1). We chose a factorial
design since it enables simultaneous investigation of two
interventions by including all participants in both ana-
lyses which is highly cost-efficient. Furthermore, they
allow for evaluation of both the separate effects of each
intervention and the benefits of receiving both [35]. Be-
cause our participants reported engaging in both risky
injection drug use and unprotected sex, we felt ethically
mandated to provide education on safer injection or
safer sex to all women enrolled in the trial. Therefore,
each of the four conditions included either an interactive
or didactic version of the injection risk intervention and
the sexual risk intervention, which were 30 minutes
each. Thus, each of the 4 conditions took approximately
60 minutes to complete, which ensured that any
observed differences at follow-up were not due to the at-
tention an individual group received. By including a
group that received both interactive interventions, it
would be possible to determine if FSW-IDUs require ac-
tive skills training on both sexual and injection risk
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Figure 1 Design of 2×2 factorial trial to simultaneously evaluate injection and sexual risk reduction interventions.
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achieve similar effect sizes. Experienced interviewers
who were indigenous to these communities were trained
to deliver this intervention. Each condition is described
below.Group A: Didactic injection risk intervention and didactic
sexual risk intervention (60 minutes)
Participants assigned to Group A represented the con-
trol condition. They received information on both safer
injection and safer sex that was delivered in a lecture-
style format and contained information in printed mate-
rials available at local health centers. Counselors were
instructed not to encourage discussion.
Didactic injection risk intervention (30 minutes). Parti-
cipants received a didactic presentation where the
counselor stressed the importance of using sterile injec-
tion equipment to protect against HIV and viral hepatitis
and the risks of transmission from sharing injection
equipment. The counselor referred women to the local
needle exchange and provided the participant with
instructions on how to disinfect syringes with bleach in
instances where they could not obtain a sterile syringe.
This module was designed as to impart education only;no theory-driven active skills building elements oriented
towards safer injection were included.
Didactic sex risk intervention (30 minutes). The didac-
tic version of the safer sex intervention was based on a
modified version of the CDC guidelines for HIV counsel-
ing, testing, and referral [36] and materials from CEN-
SIDA that were used in the control condition of Mujer
Segura [17]. In this component, there were no theory-
driven active skill building elements oriented towards
safer sex.Group B: Interactive injection risk intervention and didactic
sexual risk intervention (60 minutes)
Women randomized to this group received the inter-
active injection risk reduction intervention (described
below) and the didactic sexual risk intervention (i.e.,
same module as in Group A).
Interactive Injection Risk Intervention (30 minutes):
The injection risk intervention incorporated principles
of Motivational Interviewing, Social Cognitive Theory
(SCT), and Theory of Reasoned Action (TRA). It was
based on components from two multi-site randomized
behavioral intervention trials conducted in the U.S. that
focused on reducing injection risks among HIV-negative
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ively; STRIVE (Study To Reduce Intravenous Exposures)
[37] and DUIT (Drug User Intervention Trial) [30]. Both
interventions were shown to be highly efficacious in sig-
nificantly reducing receptive and distributive sharing of
injection equipment [38,39], and were listed as evidence
based interventions by the U.S. Center for Disease Con-
trol and Prevention (http://www.cdc.gov/hiv/topics/test-
ing/non-healthcare/index.htm) [40]. Details on how
components of these interventions were adapted for
Mujer Mas Segura are described in the Additional file 1.
On a laptop, the counselor then showed the partici-
pant a video called “Una Gota de Sangre” that was cre-
ated for Mujer Mas Segura (see Additional file 1 for
details). The video included a scene whereby a drop of
fluorescent dye was to simulate a drop of blood to show
participants how their injection equipment can become
contaminated and spread HIV or viral hepatitis if injec-
tion equipment is shared. When viewed under a black
light, the cooker, cotton, water and even the fingers of
the person preparing the injection equipment glowed in
the dark, showing that contamination from any of these
items could occur even if the syringe itself was not
shared.
This session also introduced a ‘risk ladder’ whereby
participants actively learned how to lower their risk of
infection, even if they could not eliminate it entirely.
This exercise depicted a ladder with ten rungs and ten
cards, each with an accompanying diagram ordered from
least risky (i.e. not using drugs) to most risky (i.e., using
somebody’s syringe, etc.), and an action item for each
that was written on a flash card. The woman was asked
to read each card aloud (or if she could not read, the
counselor did it for her). The participant was asked to
place the card along the ladder, justifying its location de-
pending on the amount of risk each action had for trans-
mitting a blood borne infection. The counselor then
used motivational interviewing techniques (e.g., key
questions, reflective listening, summarization, affirm-
ation) to elicit information on the woman’s own risky in-
jection behaviors, asking her to reflect on the reasons
why she shared injection equipment. Reasons mentioned
by project participants included but were not limited to:
dependence on someone else for drugs and/or injection
equipment, ignorance or fear of where to obtain sterile
equipment, and inability to inject herself. Helping the
participant understand motivations that underlie sharing
injection equipment in different situations was posited
to be a prerequisite to behavior change. Using the “deci-
sional balance” approach that is a key tenet of motiv-
ational interviewing (MI) [41], the counselor asked the
participant to describe the pros and cons of a specific
activity—sharing equipment, not using clean works, be-
coming HIV positive—in order to facilitate the personalrealization that these behaviors contained more serious
negative than positive outcomes. Since female IDUs in
Tijuana and Cd. Juarez reported that their sex partners
often influenced their drug use [42], the counselor
prompted the participant to verbally propose possible
solutions such as (1) obtaining and carrying their own
injection equipment; ("works") (2) suggesting that each
partner use his or her own "works", or as a last resort,
(3) using bleach to disinfect the syringe before using it.
As the counselor and participant discussed these under-
lying motivations, the woman gained insight into her be-
havior and began to build motivation for change. This
was accomplished by eliciting self-motivated reasons for
change and enhancing the participant's self-efficacy for
change. A role play was then used to help her identify
barriers to safer injection using, based on one of three
potential injection scenarios (i.e. injecting with a client,
sex partner, female friends); each woman chooses a sce-
nario most applicable to her situation. Through the role
play, women practiced negotiating skills to empower
them not to share their injection equipment and to ex-
plain this to those they most commonly injected with.
Finally, women were taught how to disinfect their syr-
inges with bleach, not as a means to replace sterile syr-
inge use, but as a last resort when it was not possible to
use sterile syringes (e.g., during incarceration). This pro-
vided women with the skills to reduce their risk of infec-
tion even in the most undesirable circumstances, which
led the women in our pilot study to feel that they really
could change their lives. Through these exercises,
women were encouraged to verbally state at least one at-
tainable goal to reduce their injection risks (e.g., avoid
being high with clients or wait until after sex to use
drugs, obtain their own sterile syringe and ‘works’ before
using, bleach used syringes). In total, the interactive in-
jection risk intervention was 30 minutes in length.
Group C: Interactive sexual risk intervention condition and
didactic injection risk intervention condition (60 minutes)
Women randomized to this intervention received the
interactive sexual risk reduction intervention (described
below), and the didactic injection risk intervention
described previously (see Group A).
Interactive Sexual Risk Intervention (30 minutes). The
interactive sexual risk intervention was based on compo-
nents that were included in two interventions that were
conducted previously; Mujer Segura [17] and Fastlane
[43], both of which combined the principles of SCT and
TRA and used MI to increase condom use. Mujer
Segura provided FSWs in Tijuana and Cd. Juarez with
an interactive intervention aimed at improving their
ability to negotiate condom use with clients, but did not
take into account the effects of substance use by either
partner. Fastlane provided heterosexual, HIV-negative
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the context of their drug use, but was a multi-session
intervention. Thus, the Mujer Segura intervention was
adapted to incorporate strategies for negotiating condom
use within the context of their own, or their partner’s
substance use, and was extensively piloted to ensure that
it was deemed appropriate for FSW-IDUs in our cultural
context.
First, the counselor asked the participant questions
about condom use and drug or alcohol use during sex,
including her perceived need to change, perceived possi-
bility of change, self-efficacy for change, and stated
intentions to change, working to increase her awareness
of unsafe sex and associated risks (e.g., HIV, STIs, preg-
nancy). MI techniques were used to elicit information
on her current situation and motivations to help her see
her situation clearly and accurately. Based on our pilot
work, the lure of more money and drugs is a major rea-
son for not using condoms with clients, whereas power
differentials, fear and dependence on her partner for
drugs were possible reasons for not using condoms with
regular or casual partners. Counselors used the “decisio-
nal balance” approach to help the participant articulate
that, in most cases, reasons for using condoms strongly
outweighed reasons for not doing so. For example, the
majority of participants in our study were engaged in
sex work to support their children, for whom they
wanted to stay healthy. Participants who felt that they
could not abstain from drug use were counseled to
recognize that by avoiding being high during sexual
transactions, they were in a better position to prevent
clients from taking advantage or abusing them, and to
successfully negotiate condom use.
Once the balance began to shift in favor of positive
change, the next step was to help the participant develop a
plan of action that best suited her personal situation. The
participant was asked to identify barriers to safer sex which
typically included the threat of physical assault or death,
rape, loss of clients, and, with loss of income, the emer-
gence of withdrawal symptoms (‘malilla’). The counselor
then worked with the participant to problem-solve these
barriers, offering suggestions on how to change behavior
and illustrating positive outcomes. The participant then ac-
tively became involved in problem-solving and encouraged
to come up with solutions. She was presented with a menu
of safer sex options ranging from using condoms, offering
oral sex instead of unprotected vaginal or anal sex, avoid-
ing sex when high on drugs, waiting to use drugs after sex
and avoiding violent clients. According to both MI and
SCT, belief in one's ability to bring about change is an im-
portant motivator of change. It was very important that the
participant attributed success to herself. The counselor
helped the woman define achievable goals (e.g., always use
a condom for vaginal and anal sex with clients or alwaysusing new, sterile works when injecting drugs). Once the
participant had defined goals and arrived at a plan of ac-
tion, the participant and counselor engaged in a role-play.
Alternate strategies for dealing with the situation were dis-
cussed, where the woman was rewarded with positive feed-
back to promote self-efficacy.
The counselor aimed to strengthen the woman’s com-
mitment to using condoms by exploring ways to make
condom use exciting and erotic. She showed the partici-
pant how to put a condom on properly, and encouraged
the participant to practice putting a condom on and off
a penis model while discussing how to keep it erect. As
we had observed in Mujer Segura, many women did not
know how to use a condom properly [32]; most reported
experiences where condoms broke or stayed inside the
vagina, especially when the woman and/or her partner
were high. During our pilot work, FSWs expressed grati-
tude for the condom demonstration and the information
regarding proper condom use that were designed to en-
hance participants’ attitudes, self-efficacy, outcome ex-
pectancies, and intentions to use condoms.
Group D: Interactive injection risk intervention and
interactive sexual risk intervention (60 minutes)
Women randomized to this group received both the
interactive injection risk intervention and the interactive
sexual risk intervention, which were described above.
Outcome ascertainment
To ascertain HIV status, the “Determine”W rapid antibody
test was used (Abbott Pharmaceuticals, Boston, MA). All
reactive samples were tested using an HIV-1 enzyme im-
munoassay and immunofluorescence assay. Syphilis ser-
ology used the rapid plasma reagin (RPR) test (Determine™
Syphilis TP; Abbott Pharmaceuticals, Boston, MA). Posi-
tive samples were subjected to confirmatory testing using
the Treponema pallidum particle agglutination assay
(TPPA) (Fujirebio, Wilmington, DE, USA). Initially, testing
for Gonorrhea and Chlamydia was conducted using a rapid
test kit (BioStarW OIAW GC and CHLAMYDIA) and posi-
tive samples were confirmed on urine specimens using
TMA (Genprobe, San Diego, CA). On March 24, 2009, the
CT/GC protocol was modified to requesting urine samples
from all project participants to accommodate GC/CT
screening using the Genprobe Transcription-Mediated
Amplification assay (TMA; San Diego, CA). The change in
protocol was prompted by the release of a report from the
US Centers for Disease Control and Prevention that ques-
tioned the sensitivity of the BioStar rapid GC test [44].
Trichomonas vaginalis was detected using the OSOMW
Trichomonas Rapid Test, and Bacterial Vaginosis using the
OSOMW BVBlueW Test (Genzyme diagnostics, San Diego,
CA). The San Diego County Health Department (SDCPHL)
conducted all confirmatory tests.
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mens were obtained by venipuncture, centrifuged on
site, and split into three aliquots. Two vaginal swabs
were obtained by a trained nurse (one for gonorrhea and
one for Chlamydia testing). Specimens were labeled with
the participant’s unique study ID#, date of birth and col-
lection date. Serum was batched and stored at −20
degrees Celsius in on-site freezers until their transport
to San Diego on a weekly basis.
Biological sample transport
Every effort was made to conduct confirmatory testing lo-
cally; however, due to infrastructure and cost-effectiveness
biological samples had to be shipped to San Diego for con-
firmatory testing. Participant samples collected in Ciudad
Juarez were shipped to Tijuana via authorized commercial
courier (DHL) en route to their final destination in San
Diego. Transport of samples constituted a binational effort
with the SDCPHL, the State Health Secretary of Baja
California and UCSD. A US Centers for Disease Control and
Prevention (CDC) permit for the importation of biological
samples was secured for the duration of the study and sam-
ples were prepared following municipal, state and inter-
national standards that regulate the handling, packing,
transporting and delivery of biological specimens in Mexico
and the U.S. Cross-border transport of samples followed a
weekly schedule and was facilitated by a ‘SENTRI’-card
holder issued to SDCPHL or UCSD staff.
Pre- and post-test counseling and referrals
After the behavioral interview and before the HIV/STI
rapid testing was conducted, pre-test counseling for
HIV/STI testing was performed as per CDC and Mexi-
can Health Norm guidelines. Results from the rapid
HIV/STI tests were ready within 30 minutes, at which
time the results were read by a trained counselor and
shared with the participant in a private room. Specimens
testing positive were immediately repeated with a second
rapid test. Participants with an indeterminate or reactive
HIV rapid test were referred to Municipal specialty
clinic (CAPASITS) for further expedited follow up due
to the delay in the availability of the study’s confirmatory
test results. Women who tested HIV-positive at baseline
were invited to continue in the study to protect their
confidentiality but were not included in outcome
analyses.
For those participants testing positive on rapid tests to
Chlamydia, Gonorrhea, Trichomonas, bacterial vaginosis
and syphilis, we provided treatment on the spot while
confirmatory testing was being conducted as appropri-
ate. When the gonorrhea rapid test was taken off the
market as noted above, we revised the protocol to pro-
vide treatment for Chlamydia and Gonorrhea regardless
of test results at baseline. In cases of active syphilis (e.g.,titers >=1:8), subjects were eligible under Mexico Minis-
try of Health guidelines for free Penicillin benzatinic
treatment regardless of health insurance status. For Tri-
chomonas and bacterial vaginosis cases, participants
were administered metronidazole and clindamycin. For
gonorrhea and Chlamydia, a one-time antibiotic treat-
ment appropriate for high-risk groups was administered
(i.e., Ciprofloxacin, Ceftriaxone and/or Azithromycin)
for all women regardless of their randomization assign-
ment, at baseline and follow-up. Study nurses adminis-
tered all STI medications and provided referrals to
municipal clinics when additional medical attention was
warranted. Participants were asked to return within one
month to receive STI confirmatory test results.
Participant incentives
Enrolled participants received reimbursements ranging
from $5 to $25 dollars upon completion of specific study
activities as follows: a) Five dollars was provided for
completing study screening, STI treatment, and locator
visits; b) Twenty-five dollars was provided upon comple-
tion of each baseline and quarterly follow-up visit.
Follow-up interviews
Follow-up interviews were conducted at 1-, 4-, 8-, and
12-month post-randomization and were interviewer-
administered using CAPI. The 1-month follow-up visit
was scheduled for all participants regardless of group as-
signment to receive their confirmatory test results. In
addition, all participants underwent the supplemental
survey, described above. At quarterly follow-up visits,
participants were re-tested for HIV and STIs and under-
went follow-up interviews with recall periods that re-
ferred to the period since the last interview.
Cohort retention
A number of strategies were used to minimize attrition.
Participants were asked to update their contact informa-
tion every 4 months in “locator” forms completed by
field staff. These locator visits were staggered in between
the quarterly follow up interviews. We also implemented
street tracking and posted notices at shelters, clinics and
drug treatment programs to serve as a visual reminder
in public places. The notices only referenced the name
of the project, address and phone number of the offices
and encouraged participants to call in. Each month, the
field coordinator printed a list of those due for an ap-
pointment and for those participants who missed their
appointments, staff would use the information on the lo-
cator forms to actively reach out to them.
Other follow-up strategies included obtaining permis-
sion from our institutional review boards in the U.S. and
Mexico and the U.S. Office of Human Research Protec-
tions to revise our informed consent forms to enable
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cerated. Approval was granted to allow project staff to
post a project notice in the nursing station and/or lobby
of the institutions and participants who recognized the
project information would sign their name up on a pro-
ject list to be interviewed inside the institution at a later
time. Project staff would contact the Institution contact
on a regular basis to check whether any names had been
added to the list.
In addition, the municipal and state health authorities
in Mexico issued official letters (known as “Oficios”) sup-
porting the study and requesting the support of other
institutions. We obtained Oficios from the State HIV/
STI Coordinator, the State Secretary of Health, and the
Head of Municipal Health Jurisdiction. The authorities
at the local penitentiary and directors of the drug re-
habilitation centers were formally contacted and they all
honored the Oficios from the Health authorities and
granted access to study participants housed at their
facilities.
Finally, our local NGO partners provided project parti-
cipants with a picture identification (ID) card that served
as an informal personal identification card that was
honored by most law enforcement and health author-
ities. The ID card indicated membership to a health pro-
gram and did not include any information that would
reveal the nature of the study to preserve the partici-
pant’s confidentiality. This ID card helped study staff
confirm the identity of participants at follow-up.Fidelity
We employed the following measures to ensure the fi-
delity of our interventions: First, all counselors under-
went intensive training. Second, a random 10% of
counseling sessions were taped with the participant’s
permission and were reviewed by the project director
and scored for fidelity to the intervention messages. Im-
mediate corrective action and re-training was under-
taken when necessary.Contamination
There were at least two potential sources of contamination
between intervention arms: (i) our counselors and (ii)
cross-talk between women assigned to different conditions.
Rigorous training and fidelity checks helped guard against
contamination introduced by our counselors. We have
found that between-participant contamination is rare (i.e.
<1% in Mujer Segura). Nevertheless, at follow-up, we asked
women if they talked about safer sex or safer injection with
another FSW, and if so what the conversation consisted of.
If needed, this information can be used as a covariate in
our analyses. Despite training, a potential source of bias
could be introduced by staff who were aware of subjects’group assignment. At follow-up, interviewers remained
blind to group assignment.
Power calculations
The primary outcome is combined HIV/STI incidence
(i.e., confirmed incident cases of HIV, syphilis, gonor-
rhea, chlamydia, and trichomonas (bacterial vaginosis
was not included). Secondary outcomes are reductions
in sharing of injection equipment and unprotected sex
with clients. We calculated power a priori for our pri-
mary outcome (combined HIV/STI incidence), as well as
several secondary outcomes (changes in receptive needle
sharing, sharing of injection equipment, and condom
use with clients). These are described in detail in Add-
itional file 2. These calculations suggested that with an
anticipated sample size of 600 participants and a conser-
vative estimate of 20% attrition (N= 480), we would have
good power to detect differences across a wide range of
possible effect sizes. As shown in Figure 2, 567 women
were eligible for analysis due to retention rates that were
higher than anticipated (i.e., >90% at each visit at both
sites). The study was not originally powered to conduct
site-specific analyses.
Results
A total of 584 eligible FSW-IDUs were recruited into the
study, 284 in Tijuana and 300 in Ciudad Juarez. As
shown in the CONSORT diagram in Figure 2 and
Table 1, a total of 1,132 women were screened for par-
ticipation, of whom 548 (48.4%) were excluded for the
following reasons: 487 (88.9%) were ineligible, and 61
screened as eligible but later did not appear for their
interview after they were referred, which can be conser-
vatively interpreted as refusal (11.1%). The main reasons
for ineligibility were not having unprotected sex with cli-
ents in past month (64%), not injecting drugs in past
month (60%), not having exchanged sex for money,
drugs, shelter, goods, etc. (45%), and among those who
had injected in the past month, not having shared nee-
dles or injection paraphernalia (32%). Participants could
be disqualified for more than one reason.
Of the 584 eligible women who provided informed
consent, all completed the baseline interview, provided
biological samples and were randomized at the same
visit: 144 were assigned to Group A, 146 to Group B,
148 to Group C and 146 to Group D. During follow-up,
a total of 17 participants (2.91%) were lost to follow-up
(i.e., did not present for at least one follow-up interview)
with death (10/17) being the most common reason
(58.8%). All ten deaths were deemed unrelated to study
participation by the UC San Diego ethics committee.
The remaining 7 participants could not be located. None
of the participants who were lost to follow-up withdrew
from the study. Therefore, a total of 567 participants
Assessed for Eligibility (n=1132) 
Randomized (n=584) 
Excluded (n=548) 
Not meeting inclusion criteria (n=487)* 
Refused to participate (n=61) 
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Figure 2 “CONSORT diagram for participants screened, enrolled, randomized and analyzed in Mujer Mas Segura”.
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Group A, 143 in Group B, 143 in Group C and 142 in
Group D.
Table 2 provides detailed information about the socio-
demographics and baseline characteristics of the 584
participants, overall and by group assignment. Overall,Table 1 Reasons for not meeting inclusion criteria for the Mu
Disqualification reason
Did not share needles/syringes/injection paraphernalia in the past month
Did not have unprotected sex with clients in the past month
Did not inject drugs in the past month
Did not exchange sex for money/drugs/shelter/goods in the past month
HIV-positive
Plans to move in the next 18 months
Age <18
Started sex work < a month ago
†Numbers do not add to 100% because women could be disqualified for more thanthere were few significant differences between the four
groups, suggesting that randomization was successful. A
marginally higher proportion of participants receiving
both interactive intervention conditions (group D)
reported obtaining sterile syringes from needle exchange










one reason; *among those who injected in the past month (n = 194).



















Age (years) 33(27,42) 32(27,40) 34(29,40) 34(28,40) 33(27,40) .55
# of years of education completed 7(5,9) 6(5,9) 6(5,9) 6(6,9) 6(5,9) .94
Speaks English 45(31.3%) 43(29.5%) 31(20.9%) 38(26.0%) 157(26.9%) .20
Has a spouse or steady partner 57(39.6%) 54(37.0%) 48(32.4%) 66(45.2%) 225(38.5%) .15
Earns average of > = 350 USD** 63(43.8%) 75(51.7%) 69(47.6%) 69(47.3%) 276(47.6%) .60
# years lived in the city of interview 22(9,31) 21(10,29) 23(10,33) 23(12,34) 22(10,33) .43
Injection Drug Use History and Risks
Age when first injected drugs 21(17,27) 19(17,24) 19(16,27) 20(18,24) 20(17,26) .45
Injected>= once per day** 137(95.1%) 140(95.9%) 135(91.2%) 137(93.8%) 549(94.0%) .35
Obtained syringes from needle
exchange**
7(4.9%) 14(9.6%) 19(12.8%) 20(13.8%) 60(10.3%) .05
Syringe confiscated by police in
exchange for not being arrested**
41(28.5%) 39(26.9%) 43(29.3%) 40(27.4%) 163(28.0%) .97
Often/always injected drugs with a
client**
46(31.9%) 41(28.3%) 44(29.7%) 55(37.7%) 186(31.9%) .33
Receptive needle sharing** 140(97.2%) 140(95.9%) 143(96.6%) 138(95.2%) 561(96.2%) .81
Divided drugs with used syringe** 101(70.6%) 111(76.6%) 104(70.7%) 84(57.5%) 400(68.8%) .00
Used a cooker after someone else had
used it**
138(96.5%) 140(95.9%) 144(97.3%) 139(95.9%) 561(96.4%) .90
Used a cotton filter after someone else
had used it**
128(88.9%) 127(87.0%) 130(87.8%) 128(88.3%) 513(88.0%) .97
Sharing rinse water 137(95.8%) 138(94.5%) 139(94.6%) 135(93.1%) 549(94.5%) .80
Injection Risk Index Score*** 3.4( 2.4,4.2) 3.6( 2.4,4.2) 3.6( 2.4,4.0) 3.6( 2.4,4.2) 3.6( 2.4,4.2) .70
Self-efficacy score for safer drug
injection
2.0( 1.8,2.5) 2.1( 2.0,2.7) 2.0( 1.8,2.6) 2.0( 2.0,2.7) 2.0( 1.8,2.7) .67
Age when began to work regularly as
a FSW
19(15,25) 19(16,25) 19(16,24) 20(17,25) 19(16,25) .22
# Unprotected vaginal/anal sex acts
with spouse/steady partner**
8(1,30) 12(4,30) 12(4,30) 8(3,26) 9(3,30) .53
Income earned from sex (USD)** 885 (286,1883) 975 (440,1740) 1050 (450,1660) 906 (420,1860) 960 (420,1800) .97
# male clients** 28(10,80) 30(10,84) 38(11,76) 31(14,74) 30(10,80) .81
# vaginal/anal sex acts with clients** 49(15,109) 57(20,96) 52(20,111) 50(21,100) 51(20,101) .94
# unprotected vaginal or anal sex acts
with clients**
27(6,60) 30(12,57) 33(8,63) 30(8,58) 30(9,60) .86
Self-efficacy for condom use score 3.0( 2.4,3.0) 3.0( 2.6,3.0) 3.0( 2.6,3.0) 3.0( 2.8,3.0) 3.0( 2.6,3.0) .17
Sex Work History and Risks
Amount earned per vaginal sex act
without condom (USD)
20(13,30) 20(15,30) 20(10,30) 20(15,30) 20(15,30) .95
Arrested in the past 6 months 68(47.2%) 69(47.6%) 64(43.5%) 61(42.1%) 262(45.1%) .73
HIV/STI Services and Laboratory Test Results
Ever had an HIV test 74(51.4%) 76(52.1%) 76(51.4%) 66(45.5%) 292(50.1%) .65
Has seen more access to condoms* 38(26.8%) 40(28.6%) 44(30.8%) 43(30.1%) 165(29.0%) .88
Has seen more access to sterile
syringes*
34(23.9%) 36(25.5%) 42(29.6%) 52(36.1%) 164(28.8%) .10
105(75.5%) 117(81.8) 116(81.1) 110(78.0) 448(79.2%) .54
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Table 2 Descriptive statistics of Mujer Mas Segura participants by intervention group at baseline (n =584) (Continued)
Reports ‘easy access’ to sterile
syringes
Tested positive for syphilis 35(24.5%) 36(25.0%) 37(25.3%) 34(23.4%) 142(24.6%) .98
Syphilis titers > =1:8, among lifetime
syphilis cases
10(28.6%) 16(43.2%) 11(29.7%) 12(35.3%) 49(34.3%) .54
Tested positive for gonorrhea 6(4.2%) 4(2.7%) 1(0.7%) 2(1.4%) 13(2.2%) .19
Tested positive for Chlamydia 19(13.2%) 22(15.1%) 10( 6.8%) 19(13.0%) 70(12.0%) .14
Tested positive for trichomonas 40(27.8%) 50(34.2%) 57(38.5%) 49(33.6%) 196(33.6%) .28
Tested positive for bacterial vaginosis 60(41.7%) 61(41.8%) 62(41.9%) 45(30.8%) 228(39.0%) .14
*past year; **past month;
*** Calculated based on methods used in the DUIT intervention [38], comprised of the following: receptive needle sharing, sharing a cooker, cotton filter, or rinse
water to prepare drugs for injection after someone else had used it, and using a used syringe to divide drugs. The score was constructed by calculating the
average between the responses to these five injection risk indicators (1 = never, 2 = sometimes, 3 = about half the time, 4 = often, and 5 = always), with higher
scores representing higher risk.
**** Numbers associated with the continuous variables represent Medians and Interquartile Ranges.
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used syringe (p < 0.001) compared to participants in the
control group (group A). Otherwise, all four groups were
balanced with respect to other demographic and baseline
behavioral characteristics, as well as self-reported ease of
accessing syringes (p > .05).
Sociodemographics
Median age, years of education completed and length of
residence in the city of interview were 33, 6 and 22 years,
respectively.
Injection drug use history and risks
The median age of first drug injection was 20 years
(interquartile range [IQR]: 17–26 years). Regardless of
group assignment, most participants reported injecting
more than once a day (94%). By definition, all reported
either receptive needle sharing or injection with used in-
jection equipment within the last month (e.g., receptive
needle sharing: 96.2%; sharing a cooker: 96.4%; sharing a
cotton filter: 88.0%; sharing rinse water: 94.5%). An in-
jection risk score was calculated based on methods used
in the DUIT intervention [38] study, and was comprised
of the following injection risk indicators: receptive nee-
dle sharing, sharing a cooker, cotton filter, or rinse water
to prepare drugs for injection after someone else had
used it, and using a used syringe to divide drugs. The
questions regarding these indicators included five item
categories (1 = never, 2 = sometimes, 3 = about half the
time, 4 = often, and 5 = always). The injection risk score
was constructed by calculating the average between the
responses to the five injection risk indicators, with
higher scores representing higher risk. There were no
significant differences in the Injection Risk Index Score
across conditions, nor the reported Self-efficacy Score
for Safer Drug Injection (Table 2).Sex work history and risks
The median age of sex work initiation was 19 years
(IQR: 16–25 years). Participants reported having a me-
dian of 30 (IQR: 10–80) clients and 30 unprotected vagi-
nal/anal sex acts with clients in the last month (IQR: 9–
60). There were no significant differences in the self-
efficacy for condom use score across conditions.HIV/STI services and lab test results
Fifty percent of the sample reported ever having an HIV
test. Slightly less than one-third of the sample reported
noticing more access to condoms (29.0%) and sterile syr-
inges (28.8%) in the last year. At baseline, one quarter of
the sample tested positive (24.6%) for syphilis, of whom
34.3% had titers >=1:8, which is consistent of active in-
fection. Prevalence of other STIs were: Bacterial Vagin-
osis: 39%; Trichomonas: 33.6% and Chlamydia: 12%. The
prevalence of gonorrhea at baseline was only 2.2%.Site differences
Table 3 compares participants in terms of sociodemo-
graphics, risk behaviors and HIV/STI results by study
site.Sociodemographics
Compared to participants in Cd. Juarez, Tijuana partici-
pants reported higher levels of formal education (8 vs.
6 years, p = <.001) and a higher proportion spoke English
(41.5% vs. 13%, p = <.001). On the other hand, a higher
proportion of Cd. Juarez participants reported earning >
$350 dollars in last month (60% vs. 34.3%, p = <.001)
and had lived in their city of residence for longer dura-
tions (median: 26 vs. 16 years, p = <.001), relative to par-
ticipants in Tijuana.
Table 3 Descriptive statistics of Mujer Mas Segura participants by location: Tijuana (n = 284) versus Ciudad Juarez
(n =300)
Variable Tijuana (n =284) Ciudad Juarez (n = 300) Total (n = 584) p
Sociodemographics
Age (years) 34(28,41) 33(27,39) 33(27,40) .11
# of years of education completed 8(6,10) 6(4,8) 6(5,9) <.001
Speaks English 118(41.5%) 39(13.0%) 157(26.9%) <.001
Has a spouse or steady partner 107(37.7%) 118(39.3%) 225(38.5%) .68
Earns average of > = 350 USD** 96(34.3%) 180(60.0%) 276(47.6%) <.001
# years lived in the city of interview 16(8,29) 26(18,34) 22(10,33) <.001
Injection Drug Use History and Risks
Age when first injected drugs 20(17,24) 20(17,27) 20(17,26) .47
Injected>= once per day** 275(96.8%) 274(91.3%) 549(94.0%) .005
Obtained syringes from needle exchange** 26(9.2%) 34(11.3%) 60(10.3%) .39
Syringe confiscated by police in exchange for not being arrested** 78(27.7%) 85(28.3%) 163(28.0%) .86
Often/always injected drugs with a client** 134(47.3%) 52(17.3%) 186(31.9%) <.001
Receptive needle sharing** 271(95.8%) 290(96.7%) 561(96.2%) .57
Divided drugs with used syringe** 178(63.3%) 222(74.0%) 400(68.8%) .006
Used a cooker after someone else had used it** 274(97.2%) 287(95.7%) 561(96.4%) .33
Used a cotton filter after someone else had used it** 256(90.5%) 257(85.7%) 513(88.0%) .08
Shared rinse water 266(94.7%) 283(94.3%) 549(94.5%) .86
Injection Risk Index Score 3.6(2.4,4.2) 3.2(2.4,4.0) 3.6(2.4,4.2) .00
Self-efficacy score for safer drug injection 2.0(2.0,2.8) 2.0(1.8,2.7) 2.0(1.8,2.7) <.001
Sex Work History and Risks
Age when began to work regularly as a FSW 20(17,25) 19(16,25) 19(16,25) .02
# Unprotected vaginal/anal sex acts with spouse/steady partner** 9(2,30) 10(4,30) 9(3,30) .42
Income earned from sex (USD)** 770( 305,1500) 1140( 540,1896) 960( 420,1800) <.001
# male clients** 15(6,30) 68(30,104) 30(10,80) <.001
# vaginal/anal sex acts with clients** 34(12,60) 84(40,127) 51(20,101) <.001
# unprotected vaginal or anal sex acts with clients** 25(5,56) 33(12,65) 30(9,60) <.001
Self-efficacy for condom use score 3.0( 2.6,3.0) 3.0( 2.6,3.0) 3.0( 2.6,3.0) .82
Amount earned per vaginal sex act without condom (USD) 25(20,35) 15(10,20) 20(15,30) <.001
Arrested in the past 6 months 115(40.9%) 147(49.0%) 262(45.1%) .05
HIV/STI Services and Laboratory Test Results
Ever had an HIV test 144(50.9%) 148(49.3%) 292(50.1%) .71
Has seen more access to condoms* 113(42.2%) 52(17.3%) 165(29.0%) <.001
Has seen more access to sterile syringes* 116(43.0%) 48(16.1%) 164(28.8%) <.001
Reports ‘easy access’ to sterile syringes 238(88.5%) 210(70.7%) 448(79.2%) <.001
Tested positive for syphilis 46(16.2%) 96(32.7%) 142(24.6%) <.001
Syphilis titers > =1:8, among lifetime syphilis cases 23(50.0%) 26(26.8%) 49(34.3%) .006
Tested positive for gonorrhea 5(1.8%) 8(2.7%) 13(2.2%) .46
Tested positive for Chlamydia 28(9.9%) 42(14.0%) 70(12.0%) .12
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Table 3 Descriptive statistics of Mujer Mas Segura participants by location: Tijuana (n = 284) versus Ciudad Juarez
(n =300) (Continued)
Tested positive for trichomonas 102(35.9%) 94(31.3%) 196(33.6%) .24
Tested positive for bacterial vaginosis 70(24.6%) 158(52.7%) 228(39.0%) <.001
*past year; **past month.
*** Calculated based on methods used in the DUIT intervention [38], comprised of the following: receptive needle sharing, sharing a cooker, cotton filter, or rinse
water to prepare drugs for injection after someone else had used it, and using a used syringe to divide drugs. The score was constructed by calculating the
average between the responses to these five injection risk indicators (1 = never, 2 = sometimes, 3 = about half the time, 4 = often, and 5 = always), with higher
scores representing higher risk.
**** Numbers associated with the continuous variables represent Medians and Interquartile Ranges.
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In the past month, a higher proportion of Tijuana parti-
cipants reported ‘easy access’ to sterile syringes (88.5%
vs. 70.7%, p < .001), having injected drugs at least once a
day (96.8% vs. 91.3%, p = .005) and often/always injecting
drugs with a client (47.3% vs. 17.3%, p < .001), compared
to participants in Cd. Juarez. During the same time
period, Cd. Juarez participants were more likely to re-
port having divided drugs with a used syringe (74% vs.
63.3%, p = 0.006). Compared to participants in Cd.
Juarez, Tijuana participants scored higher on the Injec-
tion Risk Index (p = 0.006) but also scored higher on the
self-efficacy scale for Safer Drug Injection (p < .001).
Sex work history and risks
Compared to Tijuana participants, those in Cd. Juarez
reported earning significantly more money from sex
work (p < 0.001), had more male clients (p < 0.001), more
vaginal/anal sex acts (p < 0.001) and more unprotected
vaginal/anal sex acts in the past month (p < 0.001). How-
ever, women in Tijuana earned more money for unpro-
tected vaginal sex acts than women in Cd. Juarez
(p < .001).
HIV/STI services and STI test results
Compared to participants in Cd. Juarez, Tijuana partici-
pants reported having greater access to condoms (42.2%
vs. 17.3%, p < .001) and sterile syringes (43.0% vs. 16.1%,
p < .001) in the past year. At baseline, Cd. Juarez partici-
pants had higher prevalence of bacterial vaginosis
(52.7%. vs. 24.6%, p < .001) and lifetime syphilis (32.7%
vs. 16.2%, p < .001) than participants in Tijuana, but of
those who had ever had syphilis in their lifetime, a
higher proportion of Tijuana participants had syphilis
titers >=1:8 relative to Cd. Juarez (50% vs. 26.8%,
p = 0.006).
Discussion
Mujer Mas Segura appears to be the first intervention to
attempt to simultaneously reduce injection and sexual
risk behaviors among sex workers who inject drugs. Due
to the extreme vulnerability of this population, weelected not to have a control group that would deny
some women access to critically important information
that could prevent them from acquiring HIV or other
blood-borne or STIs. Instead, all women received similar
information regardless of group allocation; the difference
was in the format the information was delivered and the
extent to which women had an interactive role in the
way they learned about HIV risk reduction practices.
Women randomized to either the interactive injection
risk reduction or the interactive sexual risk reduction
intervention were encouraged to have an active role in
the discussion, stated intentions, role-plays and goal-set-
ting, whereas women receiving the lecture formats of
these interventions received only the information in a
one-way, didactic format. The 2x2 factorial design
should enable us to determine whether the combination
of the two interactive interventions and/or its respective
components are effective in reducing injection and/or
sexual risks, which will have direct, tangible policy impli-
cations for Mexico and potentially for other resource-
poor countries. Moreover, if either of the lecture formats
is sufficient for achieving major risk reductions, this will
have important cost implications.
Our interactive intervention modules enabled sex work-
ers to take an active, participatory role to identify their
own barriers to safer injection and safer sex and problem-
solve with the counselor to suit the context of their lives.
By teaching women how to negotiate condom use and in-
ject more safely in the context of their own drug use and
that of their clients and intimate partners, we remained
sensitive to the reality that some cannot or will not be able
to stop using drugs, even if drug treatment is available.
Members of our research team were inspired by our ex-
perience with the Fastlane study of heterosexual, HIV-
negative methamphetamine users in the United States,
which showed that it was possible for a brief, theoretically
based behavioral intervention to increase condom use
without attempting to reduce drug use [43].
A unique component of our study was the video we
incorporated into the interactive injection risk intervention,
which was adapted from a similar video that was used in
two multi-site interventions in the U.S. that were highly
Vera et al. BMC Public Health 2012, 12:653 Page 16 of 18
http://www.biomedcentral.com/1471-2458/12/653efficacious [38,39]. While we did not originally intend to
feature women in the video who were from the drug user
and sex worker communities in northern Mexico, we were
surprised that they volunteered to become ‘actors’ in a new
video during the piloting phase. The inclusion of FSWs
who were active drug injectors as actors who improvised
real-world situations they typically encountered was ex-
tremely powerful and created a product that other women
could relate to. Our approach towards community engage-
ment was consistent with the guidelines developed for
working with drug using communities, which recommends
“Nothing About Us Without Us [45].
Our comparison of sociodemographic and risk behav-
ior variables by intervention group revealed few signifi-
cant differences, suggesting that randomization was
successful in achieving balance across known - and pre-
sumably unknown- confounders. On the other hand, we
observed important site differences at enrollment that
will need to be considered in outcome analysis. This
contrasts earlier findings from Mujer Segura that sug-
gested that the HIV risks in these cities were similar
[32], at least in 2004. At baseline in Mujer Mas Segura,
women in Tijuana were significantly more likely to re-
port perceived increases in the availability of condoms
and sterile syringes and higher proportions reported easy
access to syringes compared to Ciudad Juarez. Their
experiences are consistent with federal and state-funded
initiatives to scale-up HIV prevention and harm reduc-
tion services in Tijuana, which began around 2006 [46]
in response to evidence that HIV prevalence was in-
creasing, especially among FSWs and female IDUs
[16,22,23]. Between 2007 and 2011, the main non-
governmental organization (NGO) responsible for syr-
inge exchange in Tijuana reported more than doubling
the numbers of syringes exchanged as well as a doubling
in the number of ‘prevenkits’ (i.e., kits containing bleach,
sterile water, cotton and condoms) (Dr. Remedios
Lozada, personal communication, 2012). In contrast, the
main NGO responsible for syringe exchange in Ciudad
Juarez reported a more modest increase the number of
syringes exchanged between 2007 and 2011, and virtu-
ally no distribution of prevenkits (personal communica-
tion, Maria Elena Ramos, 2012).
Other important differences in the HIV risk environ-
ment were apparent between the two cities. Compared to
participants in Tijuana, a higher proportion of women in
Ciudad Juarez reported seeing changes to the built envir-
onment (i.e., torn down buildings), which was likely a re-
sult of the city government’s decision to gentrify the zona
roja district in an attempt to suppress what had been a
highly visible sex trade. Anecdotal reports indicate that
this effort did not decrease the number of sex workers,
but instead dispersed them throughout the city. Women
in Ciudad Juarez were also more likely to report seeing anincrease in the presence of the federal army compared to
Tijuana, which is not unexpected given that mobilization
of the federal army was Mexican President Calderon’s re-
sponse to an extended period of escalating violence in
Ciudad Juarez. Finally, women in Ciudad Juarez were
more likely to have greater numbers of clients, but earned
less per sex act than women in Tijuana.
The stark differences between factors in the HIV risk
environment that may influence women’s ability to
reduce high risk behaviors or adopt more protective
behaviors in these cities represents a unique opportunity
to examine a natural experiment. Whether these envir-
onmental influences will impact the efficacy of the inter-
active safer sex intervention, the interactive safer
injection intervention, or both is an open question that
will need to be explored in site-specific analyses.
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